Prevention and Control of Nosocomial Varicella During the United States Varicella Vaccination Program Era

J Infect Dis. 2022 Oct 21;226(Suppl 4):S456-S462. doi: 10.1093/infdis/jiac254.

Abstract

The United States varicella vaccination program has successfully reduced varicella incidence and hospitalizations by ≥90%, consequently reducing the risk of nosocomial exposures. However, patients and healthcare personnel (HCP) continue to introduce varicella zoster virus (VZV) into healthcare settings. Herpes zoster (HZ) is less contagious than varicella, but it can also result in exposures. Unrecognized varicella and HZ may lead to extensive contact investigations, control efforts, and HCP furloughs that result in significant disruption of healthcare activities as well as substantial costs. Robust occupational health and infection prevention programs that ensure healthcare personnel immunity and prompt recognition and isolation of patients with varicella or HZ will lower the risk of VZV transmission and reduce or eliminate the need to furlough exposed HCP and associated costs.

Keywords: herpes zoster; infection control; nosocomial infections; occupational health; outbreaks; vaccination programs; varicella; varicella zoster virus.

MeSH terms

  • Chickenpox Vaccine
  • Chickenpox* / epidemiology
  • Chickenpox* / prevention & control
  • Cross Infection* / epidemiology
  • Cross Infection* / prevention & control
  • Herpes Zoster* / epidemiology
  • Herpes Zoster* / prevention & control
  • Herpesvirus 3, Human
  • Humans
  • United States / epidemiology
  • Vaccination

Substances

  • Chickenpox Vaccine